Cargando…
Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms
Identification of genomic mutations by molecular testing plays an important role in diagnosis, prognosis, and treatment of myeloid neoplasms. Next-generation sequencing (NGS) is an efficient method for simultaneous detection of clinically significant genomic mutations with high sensitivity. Various...
Autores principales: | Rosenthal, Sun Hee, Gerasimova, Anna, Ma, Charles, Li, Hai-Rong, Grupe, Andrew, Chong, Hansook, Acab, Allan, Smolgovsky, Alla, Owen, Renius, Elzinga, Christopher, Chen, Rebecca, Sugganth, Daniel, Freitas, Tracey, Graham, Jennifer, Champion, Kristen, Bhattacharya, Anindya, Racke, Frederick, Lacbawan, Felicitas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081174/ https://www.ncbi.nlm.nih.gov/pubmed/33909614 http://dx.doi.org/10.1371/journal.pone.0243683 |
Ejemplares similares
-
Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing
por: Rosenthal, Sun Hee, et al.
Publicado: (2020) -
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory
por: Rosenthal, Sun Hee, et al.
Publicado: (2022) -
Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory
por: Guy, Carrie, et al.
Publicado: (2019) -
Describing engagement practices for the Enhance Diversity Study using principles of Tailored Panel Management
por: Ramirez, Karina D., et al.
Publicado: (2022) -
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia
por: Li, Yonghong, et al.
Publicado: (2023)